The Current State of Empirical Support for the Pharmacological Treatment of Selective Mutism

School Psychology Quarterly

Volumn 23, Issue 3, 2008, Pages 354-372

  Carlson, John S ^a   Mitchell, Angela D ^b   Segool, Natasha ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

anxiety disorders; child psychopharmacology; evidence based interventions; selective mutism

Indexed keywords

EID: 67749086475     PISSN: 10453830     EISSN: None     Source Type: Journal    
DOI: 10.1037/1045-3830.23.3.354     Document Type: Article

References (84)

1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed., text revision (2000), Author, Washington, DC
2. Barlow D.H., and Hersen M. Single-case experimental designs: Strategies for studying behavioral change (1984), Pergamon, New York
3. Bergman R.L. Integrated behavioral treatment for selective mutism (2005). http://crisp.cit.nih.gov/crisp Grant abstract retrieved on July 19, 2006, from http://crisp.cit.nih.gov/crisp
4. Bergman R.L., Piacentini J., and McKracken J.T. Prevalence and description of selective mutism in a school-based sample. Journal of the American Academy of Child and Adolescent Psychiatry 41 (2002) 938-946
5. Birmaher B., Axelson D.A., Monk K., Kalas C., Clark D., Ehmann M., et al. Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 42 (2003) 415-423
6. Black B., and Uhde T. Elective mutism as a variant of social phobia. Journal of the American Academy of Child and Adolescent Psychiatry 31 (1992) 1090-1094
7. Black B., and Uhde T. Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry 33 (1994) 1000-1006
8. Black B., and Uhde T. Psychiatric characteristics of children with selective mutism: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry 34 (1995) 847-856
9. Blanchard L.T., Gurka M., and Blackman J.A. Emotional, developmental, and behavioral health of American children and their families: A report from the 2003 National Survey of Children's Health. Pediatrics 117 (2006) 1202-1212
10. Boon F. The selective mutism controversy (continued). Journal of the American Academy of Child and Adolescent Psychiatry 33 (1994) 283
11. Boulos C., Kutcher S., Gardner D., and Young E. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. Journal of Child and Adolescent Psychopharmacology 2 (1992) 103-111
12. Carlson J.S., Kratochwill T.R., and Johnston H.F. Prevalence and treatment of selective mutism: A survey of child psychiatrists. Journal of Child and Adolescent Psychopharmacology 4 (1994) 281-291
13. Carlson J.S., Kratochwill T.R., and Johnston H.F. Sertraline treatment of 5 children diagnosed with selective mutism: A single-case research trial. Journal of Child and Adolescent Psychopharmacology 9 (1999) 293-306
14. Chavira D.A., and Stein M.B. Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder. Journal of Child and Adolescent Psychopharmacology 12 (2002) 47-54
15. Chavira D.A., and Stein M.B. Childhood social anxiety disorder: From understanding to treatment. Child and Adolescent Psychiatric Clinics of North America 14 (2005) 797-818
16. Cohan S.L., Price J.M., and Stein M.B. Suffering in silence: Why a developmental psychopathology perspective on selective mutism is needed. Journal of Developmental and Behavioral Pediatrics 27 (2006) 341-355
17. Compton S.N., Grant P.J., Chrisman A.K., Gammon P.J., Brown V.L., and March J.S. Sertraline in children and adolescents with social anxiety disorder: An open trial. Journal of the American Academy of Child and Adolescent Psychiatry 40 (2001) 564-571
18. Crumley F. The masquerade of mutism. Journal of the American Academy of Child and Adolescent Psychiatry 29 (1990) 318-319
19. Crumley F. Is elective mutism a social phobia?. Journal of the American Academy of Child and Adolescent Psychiatry 32 (1993) 1081-1082
20. Davidson J.R. Pharmacotherapy of social anxiety disorder. Journal of Clinical Psychiatry 59 S17 (1998) 47-53
21. Dow S.P., Sonies B.C., Scheib D., Moss S.E., and Leonard H. Practical guidelines for the assessment and treatment of selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry 34 (1995) 836-846
22. Dulcan M. Information for parents and youth on psychotropic medications. Journal of Child and Adolescent Psychopharmacology 2 (1992) 81-101
23. Dummit E., Klein R., Tancer N., Asche B., and Martin J. Fluoxetine treatment of children with selective mutism: An open trial. Journal of the American Academy of Child and Adolescent Psychiatry 35 (1996) 615-621
24. Dummit E.S., Klein R.G., Tancer N.K., Asche B., Martin J., and Fairbanks J.A. Systematic assessment of 50 children with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry 36 (1997) 653-659
25. DuPaul G., and Carlson J.S. Child psychopharmacology: How school psychologists can contribute to effective outcomes. School Psychology Quarterly 20 (2005) 206-221
26. Eke, A. D. (2001). Pharmacopsychosocial treatment of selective mutism: A research investigation. Unpublished doctoral dissertation, University of Wisconsin-Madison.
27. Elizur Y., and Perednik R. Prevalence and description of selective mutism in immigrant and native families: A controlled study. Journal of the American Academy of Child and Adolescent Psychiatry 42 (2003) 1451-1459
28. Ford M.A., Kratochwill T.R., Sladeczek I., and Carlson J.S. Selective mutism: Phenomenological characteristics. School Psychology Quarterly 13 (1998) 192-227
29. Freeman J.B., Garcia A.M., Miller L.M., Dow S.P., and Leonard H.L. Selective mutism. In: Morris T.L., and March J.S. (Eds). Anxiety disorders in children and adolescents (2004), Guilford, New York 280-304
30. Golwyn D.H., and Sevlie C.P. Phenelzine treatment of selective mutism in four prepubertal children. Journal of Child and Adolescent Psychopharmacology 9 (1999) 109-113
31. Golwyn D.H., and Weinstock R. Phenelzine treatment of elective mutism: A case report. Journal of Clinical Psychiatry 51 (1990) 384-385
32. Guna-Dumitrescu L., and Pelletier G. Successful multimodal treatment of a child with selective mutism: A case report. Canadian Journal of Psychiatry 41 (1996) 417
33. Hammerness P.G., Vivas F.M., and Geller D.A. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: A review of the evidence. Journal of Pediatrics 148 (2006) 158-165
34. Harvey B.H., and Milne M. Pharmacotherapy of selective mutism: Two case studies of severe entrenched mutism responsive to adjunctive treatment with fluoxetine. Southern African Journal of Child and Adolescent Mental Health 10 (1998) 59-66
35. Herxheimer A., and Mintzes B. Antidepressants and adverse effects in young patients: Uncovering the evidence. Canadian Medical Association Journal 170 (2004) 487-489
36. Jackson M.F., Allen R.S., Boothe A.B., Nava M.I., and Coates A. Innovative analyses and interventions in the treatment of selective mutism. Clinical Case Studies 4 (2005) 81-112
37. Kazdin A.E. Research design in clinical psychology (1992), Pergamon, New York
38. Kehle T.J., Madaus M.R., Baratta V.S., and Bray M.A. Augmented self-modeling as a treatment for children with selective mutism. Journal of School Psychology 36 (1998) 247-260
39. Keller M.B. The lifelong course of social anxiety disorder: A clinical perspective. Behaviour Research and Therapy 39 (2001) 273-287
40. Kessler R.C. The impairments caused by social phobia in the general population: Implications for intervention. Acta Psychiatrica Scandinavica 108 S417 (2003) 19-27
41. Kubiszyn T., Carlson J.S., and DeHay T. Pediatric psychopharmacology: An update on internalizing disorders. School Psychology Quarterly 20 (2005) 135-154
42. Lafferty J.E., and Constantino J.N. Fluvoxamine in selective mutism. Journal of American Academy of Child and Adolescent Psychiatry 37 (1998) 12-13
43. Lehman R.B. Rapid resolution of social anxiety disorder, selective mutism, and separation anxiety with paroxetine in an 8-year-old girl. Journal of Psychiatry & Neuroscience 27 (2002) 124-125
44. Liebowitz M.R. Update on the diagnosis and treatment of social anxiety disorder. Journal of Clinical Psychiatry 60 S18 (1999) 22-26
45. Lipsey M.W., and Wilson D.B. Practical meta-analysis (2001), Sage, Thousand Oaks, CA
46. Magee W.J., Eaton W.W., Wittchen H., McGonagle K.A., and Kessler R.C. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Archives of General Psychiatry 52 (1996) 159-168
47. Mancini C., Van Ameringen M., Oakman J.M., and Farvolden P. Serotonergic agents in the treatment of social phobia in children and adolescents: A case series. Depression and Anxiety 10 (1999) 33-39
48. Maskey S. Selective mutism, social phobia and moclobemide: A case report. Clinical Child Psychology and Psychiatry 6 (2001) 363-369
49. Medicines and Healthcare Products Regulatory Agency . Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants (2004). http://www.mhra.gov.uk Retrieved July 10, 2006, from www.mhra.gov.uk
50. Melfsen S., Walitza S., and Warnke A. The extent of social anxiety in combination with mental disorders. European Child and Adolescent Psychiatry 15 (2006) 111-117
51. Motavalli N. Fluoxetine for (s)elective mutism. Journal of American Academy of Child and Adolescent Psychiatry 34 (1995) 701-702
52. Nutt D.J., Bell C.J., and Malizia A.L. Brain mechanisms of social anxiety disorder. Journal of Clinical Psychiatry 59 S17 (1998) 4-11
53. Pelham W.E. Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psychology Review 22 (1993) 199-230
54. Petty F., Davis L.L., Kabel D., and Kramer G.L. Serotonin dysfunction disorders: A behavioral neurochemistry perspective. Journal of Clinical Psychiatry 57 S8 (1996) 11-16
55. Reinblatt S.P., and Walkup J.T. Psychopharmacological treatment of pediatric anxiety disorders. Child and Adolescent Psychiatric Clinics of North America 14 (2005) 877-908
56. Research Unit on Pediatric Psychopharmacology Anxiety Study Group . Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine 344 (2001) 1279-1285
57. Riddle M.A., Hardin M.T., King R., Scahill L., and Woolston J.L. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry 29 (1990) 45-48
58. Ross M.R., Powell S.R., and Elias M.J. New roles for school psychologists: Addressing the social and emotional learning needs of students. School Psychology Review 31 (2002) 43-52
59. Rupp S.N. Haloperidol for Tourette's disorder plus selective mutism. Journal of American Academy of Child and Adolescent Psychiatry 38 (1999) 7
60. Russell P.S., Raj S.E., and John J.K. Multimodal interventions for selective mutism in mentally retarded children. Journal of American Academy of Child and Adolescent Psychiatry 37 (1998) 903-904
61. Schwartz R.H., Freedy A.S., and Sheridan M.J. Selective mutism: Are primary care physicians missing the silence?. Clinical Pediatrics 45 (2006) 43-48
62. Seidel L., and Walkup J.T. Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders. Journal of Child and Adolescent Psychopharmacology 16 (2006) 171-179
63. Shear M.K., and Beidel D.C. Psychotherapy in the overall management strategy for social anxiety disorder. Journal of Clinical Psychiatry 59 S17 (1998) 39-46
64. Sheehan D.V., Raj B.A., Trehan R.R., and Knapp E.L. Serotonin in panic disorder and social phobia. International Clinical Psychopharmacology 8 S2 (1993) 63-77
65. Silva R.R., Gabbay V., Minami H., Munoz-Silva D., and Alonso C. When to use antidepressant medication in youths. Primary Psychiatry 12 (2005) 42-50
66. Silveira R., Jainer A.K., and Bates G. Fluoxetine treatment of selective mutism in pervasive developmental disorder. International Journal of Psychiatry in Clinical Practice 8 (2004) 179-180
67. Steffen R., and van Waes H. Elective mutism: Effect of dental treatment with N2/O2-inhalation sedation: Review and report of case. ASDC Journal of Dentistry for Children 13 (1999) 66-69
68. Steinhausen H.C., and Juzi C. Elective mutism: An analysis of 100 cases. Journal of the American Academy of Child and Adolescent Psychiatry 35 (1996) 606-614
69. Steinhausen H.C., Wachter M., Laimbock K., and Metzke C.W. A long-term outcome study of selective mutism in childhood. Journal of Child Psychology and Psychiatry 47 (2006) 751-756
70. Stone B.P., Kratochwill T.R., Sladeczek I., and Serlin R.C. Treatment of selective mutism: A best-evidence synthesis. School Psychology Quarterly 17 (2002) 168-190
71. Thomsen P.H., Rasmussen G., and Andersson C. Elective mutism: A 17-year-old girl treated successfully with citalopram. Nordic Journal of Psychiatry 53 (1999) 427-429
72. Tiihonen J., Kuikka J., Bergstrom K., Lepola U., Koponen H., and Leinonen E. Dopamine reuptake site densities in patients with social phobia. American Journal of Psychiatry 154 (1997) 239-242
73. United States Department of Health and Human Services . Mental health: A report of the Surgeon General (1999), U.S. Government Printing Office, Washington, DC
74. Van Ameringen M., Mancini C., and Farvolden P. The impact of anxiety disorders on educational achievement. Journal of Anxiety Disorders 17 (2003) 561-571
75. Vecchio J.L., and Kearney C.A. Selective mutism in children: Comparison to youths with and without anxiety disorders. Journal of Psychopathology and Behavior Assessment 27 (2005) 31-37
76. Velosa J.F., and Riddle M.A. Pharmacologic treatment of anxiety disorders in children and adolescents. Child and Adolescent Clinics of North America 1 (2000) 119-133
77. Velting O.N., and Albano A.M. Current trends in the understanding and treatment of social phobia in youth. Journal of Child Psychology and Psychiatry and Allied Disciplines 42 (2001) 127-140
78. Wagner K.D., Berard R., Stein M.B., Wetherhold E., Carpenter D.J., Perera P., et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Archives of General Psychiatry 61 (2004) 1153-1162
79. Westenberg H.G. The nature of social anxiety disorder. Journal of Clinical Psychiatry 59 S17 (1998) 20-24
80. Wilkins R. A comparison of elective mutism and emotional disorders in children. British Journal of Psychiatry 146 (1985) 148-203
81. Wittchen H.U., and Fehm L. Epidemiology and natural course of social fears and social phobia. Acta Psychiatrica Scandinavica 108 S417 (2003) 4-18
82. Wright H., Cuccaro M., Leonhardt T., Kendall D., and Anderson J. Case study: Fluoxetine in the multimodal treatment of a preschool child with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry 34 (1995) 857-862
83. Yeganeh R., Beidel D.C., and Turner S.M. Selective mutism: More than social anxiety?. Depression and Anxiety 23 (2006) 117-123
84. Yeganeh R., Beidel D.C., Turner S.M., Pina A., and Silverman W. Clinical distinctions between selective mutism and social phobia: An investigation of childhood psychopathology. Journal of the American Academy of Child and Adolescent Psychiatry 42 (2003) 1069-1075